Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions
Authors:
- 1 October 2019
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 33 (4) , 217-224
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health Early Independence (DP5OD019892)
- National Heart Lung and Blood Institute (R01HL13557501, P01HL132819)
This publication has 130 references indexed in Scilit:
- Immunoglobulin‐resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patientTransfusion, 2013
- Initiation and Regulation of Complement during Hemolytic Transfusion ReactionsJournal of Immunology Research, 2012
- Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapyJournal of Clinical Investigation, 2012
- Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosisBlood, 2011
- Minority donation in the United States: challenges and needsCurrent Opinion in Hematology, 2010
- Hemolysis and Hyperbilirubinemia in Antiglobulin Positive, Direct ABO Blood Group Heterospecific NeonatesThe Journal of Pediatrics, 2010
- Heme Degradation and Vascular InjuryAntioxidants & Redox Signaling, 2010
- Functions of C5a receptorsJournal of Molecular Medicine, 2009
- Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactionsBlood, 2008
- Functional roles for C5a receptors in sepsisNature Medicine, 2008